Compare BGY & UROY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BGY | UROY |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 515.6M | 601.8M |
| IPO Year | N/A | N/A |
| Metric | BGY | UROY |
|---|---|---|
| Price | $5.74 | $3.60 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 305.9K | ★ 2.5M |
| Earning Date | 01-01-0001 | 03-11-2026 |
| Dividend Yield | ★ 7.41% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $279.20 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1,584.46 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.19 | $2.13 |
| 52 Week High | $6.23 | $5.52 |
| Indicator | BGY | UROY |
|---|---|---|
| Relative Strength Index (RSI) | 51.60 | 47.00 |
| Support Level | $5.65 | $3.54 |
| Resistance Level | $5.88 | $4.07 |
| Average True Range (ATR) | 0.06 | 0.19 |
| MACD | 0.00 | -0.03 |
| Stochastic Oscillator | 70.83 | 24.73 |
Blackrock Enhanced International Dividend Trust is a diversified closed-end management investment company. Its primary investment objective is to provide current income and current gains, with a secondary objective of long-term capital appreciation. The Trust invests the majority of its net assets in dividend-paying equity securities issued by non-U.S. companies of any market capitalization, with a key focus on securities of large capitalization companies. It invests directly in such securities or synthetically through the use of derivatives.
Uranium Royalty Corp is focused on gaining exposure to uranium prices by making investments in uranium interests, including royalties, streams, debt and equity investments in uranium companies, and through holdings of physical uranium. The company operates in a single segment that is acquiring and assembling a portfolio of royalties, investing in companies with exposure to uranium and physical uranium. The Company also engages in the purchase and sale of physical uranium.